Coronavirus vaccine in India: Covaxin, Sputnik-V makers asked to submit revised proposals for human trials

covid19 reuters

Coronavirus COVID-19 vaccine tracker: Regarding Bharat Biotech’s Coronavirus vaccine candidate ‘Covaxin’, the SEC said that the design of phase 3 human trials was satisfactory “in principle”. (Reuters image) Coronavirus COVID-19 vaccine tracker: Pharmaceutical firms Dr Reddy’s Laboratories (DRL), Bharat Biotech, and Biological E (Bio E) have been directed by an expert committee set up under … Read more

Coronavirus: Who gets Covid-19 vaccine first in India? Prevent disease or check transmission, asks Dr Kang

Vaccine reuters

Coronavirus vaccine update: However, if the central government wants to “prevent transmission” then younger, working-age populations, who will be interacting more with others, should be vaccinated. (Reuters image) Coronavirus vaccine in India: Who will get the Covid-19 first in India? The question has been doing rounds after Union Health Minister Dr Harsh Vardhan announced that … Read more

Coronavirus vaccine update: Moderna’s Covid-19 vaccine unlikely to be ready before US Presidential polls

Coronavirus vaccine reuters l

Coronavirus COVID-19 vaccine update: The race to come up with a Coronavirus vaccine has become a divisive issue for the US presidential election. (Reuters image) Coronavirus vaccine: Moderna has said that its experimental vaccine candidate against Coronavirus ‘mRNA-1273’ is unlikely to be ready before the US Presidential elections 2020. The US-based pharmaceutical firm’s chief executive … Read more

Coronavirus vaccine by Oxford-AstraZeneca is ‘very close to the end’, claims Donald Trump

Donald Trump

Coronavirus vaccine update: Last month Donald Trump had said that it was possible the United States would have a coronavirus vaccine before the November 3 election. (Reuters image) Coronavirus vaccine update: Oxford-AstraZeneca’s experimental Coronavirus vaccine has entered phase 3 of human trials in the US and is “very close to the end”, announced American President Donald … Read more

First Coronavirus Vaccines may not be most effective, second line of defence is key, warn experts

COVID 19 VACCINE

Coronavirus vaccine update: So far, eight vaccine candidates are leading the race. (Reuters image) Coronavirus vaccine update: Initial Coronavirus vaccines might not be the most effective against COVID-19, experts have warned. However, experts have claimed there would be slow but steady winners of the race against the highly contagious disease. Director of the Center for Vaccines … Read more

Coronavirus Vaccine: US-based Moderna’s COVID-19 vaccine shows similar effectiveness among old, young age groups

coronavirus vaccine l 1

Results of Moderna’s vaccine have so far shown that older people were found to be more vulnerable to the highly contagious disease. (Reuters image) Coronavirus update, COVID19 vaccine tracker: US-based Moderna’s experimental coronavirus vaccine has shown similar effectiveness in older participants as well as younger volunteers. The US biotechnology company has claimed that its potential … Read more

China administering COVID-19 vaccines since July 22, says report

coronavirus vaccine reu l

Coronavirus Vaccine update: The staff of state-owned enterprises (SOEs), who were preparing to go abroad, and frontline medics were offered two choices of inactivated vaccine candidates developed by Sinopharm for urgent use. (Reuters image) China has been administering Coronavirus vaccines on workers since July 22. Last month China had “officially launched” the urgent use of the … Read more

Coronavirus vaccine: How soon all Indians can get Covid-19 vaccine? Here’s what ex-ICMR expert says

coronavirus vaccine

Coronavirus vaccine in India update: Talking about the issues of logistics of supply and accessibility to the Coronavirus vaccine, Kang said that it is nothing but a “complicated piece of the puzzle”. Coronavirus vaccine in India update, COVID19 vaccine news: COVID vaccine, when developed, is not going to be available for all people in India quickly, … Read more